In vitro antifungal susceptibilities and molecular typing of sequentially isolated clinical Cryptococcus neoformans strains from Croatia

Journal of Medical Microbiology

Volumn 60, Issue 10, 2011, Pages 1487-1495

  Mlinarić Missoni, Emilija ^a   Hagen, Ferry ^b,c   Chew, William H M ^d   Važić Babić, Verica ^a   Boekhout, Teun ^b,c   Begovac, Josip ^d,e  

^a CROATIAN NATIONAL INSTITUTE OF PUBLIC HEALTH   (Croatia)

^b CBS KNAW FUNGAL BIODIVERSITY CENTRE   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d Croatia   (Croatia)

^e UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; VORICONAZOLE;

ADULT; AGED; AMPLIFIED FRAGMENT LENGTH POLYMORPHISM; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BROTH DILUTION; CLINICAL ARTICLE; CONTROLLED STUDY; CROATIA; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; FEMALE; GENE SEQUENCE; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; MALE; MATING TYPE; MOLECULAR TYPING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEROTYPE;

ADULT; AGED; AMPLIFIED FRAGMENT LENGTH POLYMORPHISM ANALYSIS; ANTIFUNGAL AGENTS; CROATIA; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; FEMALE; GENES, MATING TYPE, FUNGAL; GENOTYPE; HIV INFECTIONS; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MOLECULAR TYPING; MYCOLOGICAL TYPING TECHNIQUES; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; SEROTYPING;

EID: 80053158982     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.031344-0     Document Type: Article

References (34)

1. Almeida, A. M., Matsumoto, M. T., Baeza, L. C., de Oliveira e Silva, R. B., Kleiner, A. A., Melhem, M. de S., Mendes Giannini, M. J. & Laboratory Group on Cryptococcosis (2007). Molecular typing and antifungal susceptibility of clinical sequential isolates of Cryptococcus neoformans from Sao Paulo State, Brazil. FEMS Yeast Res 7, 152-164.
2. Barreto de Oliveira, M. T., Boekhout, T., Theelen, B., Hagen, F., Baroni, F. A., Lazera, M. S., Lengeler, K. B., Heitman, J., Rivera, I. N. G. & Paula, C. R. (2004). Cryptococcus neoformans shows a remarkable genotypic diversity in Brazil. J Clin Microbiol 42, 1356-1359.
3. Bassetti, M., Repetto, E., Mikulska, M., Miglino, M., Clavio, M., Gobbi, M., Righi, E. & Viscoli, C. (2009). Cryptococcus neoformans fatal sepsis in a chronic lymphocytic leukemia patient treated with alemtuzumab: case report and review of the literature. J Chemother 21, 211-214.
4. Blasi, E., Brozzetti, A., Francisci, D., Neglia, R., Cardinali, G., Bistoni, F., Vidotto, V. & Baldelli, F. (2001). Evidence ofmicroevolution in a clinical case of recurrent Cryptococcus neoformans meningoencephalitis. Eur J Clin Microbiol Infect Dis 20, 535-543.
5. Boekhout, T., Theelen, B., Diaz, M., Fell, J. W., Hop, W. C. J., Abeln, E. C. A., Dromer, F. & Meyer, W. (2001). Hybrid genotypes in the pathogenic yeast Cryptococcus neoformans. Microbiology 147, 891-907.
6. Bovers, M., Hagen, F. & Boekhout, T. (2008). Diversity of the Cryptococcus neoformans-Cryptococcus gattii species complex. Rev Iberoam Micol 25, S4-S12.
7. Brandt, M. E., Pfaller, M. A., Hajjeh, R. A., Hamill, R. J., Pappas, P. G., Reingold, A. L., Rimland, D., Warnock, D. W. & Cryptococcal Disease Active Surveillance Group (2001). Trends in antifungal drug susceptibility of Cryptococcus neoformans isolates in the United States: 1992 to 1994 and 1996 to 1998. Antimicrob Agents Chemother 45, 3065-3069.
8. Casadevall, A., Spitzer, E. D., Webb, D. & Rinaldi, M. G. (1993). Susceptibilities of serial Cryptococcus neoformans isolates from patients with recurrent cryptococcal meningitis to amphotericin B and fluconazole. Antimicrob Agents Chemother 37, 1383-1386.
9. CLSI (2008). Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts. Approved Standard M27-A3. Wayne, PA: Clinical and Laboratory Standards Institute.
10. Dannaoui, E., Abdul, M., Arpin, M., Michel-Nguyen, A., Piens, M. A., Favel, A., Lortholary, O., Dromer, F. & French Cryptococcosis Study Group (2006). Results obtained with various antifungal susceptibility testing methods do not predict early clinical outcome in patients with cryptococcosis. Antimicrob Agents Chemother 50, 2464-2470.
11. Datta, K., Jain, N., Sethi, S., Rattan, A., Casadevall, A. & Banerjee, U. (2003). Fluconazole and itraconazole susceptibility of clinical isolates of Cryptococcus neoformans at a tertiary care centre in India: a need for care. J Antimicrob Chemother 52, 683-686.
12. Desnos-Ollivier, M., Patel, S., Spaulding, A. R., Charlier, C., Garcia-Hermoso, D., Nielsen, K. & Dromer, F. (2010). Mixed infections and in vivo evolution in the human fungal pathogen Cryptococcus neoformans. mBio 1, e00091.
13. Fries, B. C. & Casadevall, A. (1998). Serial isolates of Cryptococcus neoformans from patients with AIDS differ in virulence for mice. J Infect Dis 178, 1761-1766.
14. Guinea, J., Hagen, F., Peláez, T., Boekhout, T., Tahoune, H., Torres-Narbona, M. & Bouza, E. (2010). Antifungal susceptibility, serotyping, and genotyping of clinical Cryptococcus neoformans isolates collected during 18 years in a single institution in Madrid, Spain. Med Mycol 48, 942-948.
15. Hagen, F., Illnait-Zaragozi, M. T., Bartlett, K. H., Swinne, D., Geertsen, E., Klaassen, C. H., Boekhout, T. & Meis, J. F. (2010). In vitro antifungal susceptibilities and amplified fragment length polymorphism genotyping of a worldwide collection of 350 clinical, veterinary and environmental Cryptococcus gattii isolates. Antimicrob Agents Chemother 54, 5139-5145.
16. Illnait-Zaragozí, M. T., Martínez, G. F., Curfs-Breuker, I., Fernández, C. M., Boekhout, T. & Meis, J. F. (2008). In vitro activity of the new azole isavuconazole (BAL4815) compared with six other antifungal agents against 162 Cryptococcus neoformans isolates from Cuba. Antimicrob Agents Chemother 52, 1580-1582.
17. Illnait-Zaragozí, M. T., Martínez-Machín, G. F., Fernández-Andreu, C. M., Hagen, F., Boekhout, T., Klaassen, C. H. W. & Meis, J. F. (2010). Microsatellite typing and susceptibilities of serial Cryptococcus neoformans isolates from Cuban patients with recurrent cryptococcal meningitis. BMC Infect Dis 10, 289.
18. Kidd, S. E., Hagen, F., Tscharke, R. L., Huynh, M., Bartlett, K. H., Fyfe, M., Macdougall, L., Boekhout, T., Kwon-Chung, K. J. & Meyer, W. (2004). A rare genotype of Cryptococcus gattii caused the cryptococcosis outbreak on Vancouver Island (British Columbia, Canada). Proc Natl Acad Sci U S A 101, 17258-17263.
19. Kwon-Chung, K. J., Boekhout, T., Fell, J. W. & Diaz, M. (2002). Proposal to conserve the name Cryptococcus gattii against C. hondurianus and C. bacillisporus (Basidiomycota, Hymenomycetes, Tremellomycetidae). Taxon 51, 804-806.
20. López-Jodra, O., Torres-Rodríguez, J. M., Méndez-Vásquez, R., Ribas-Forcadell, E., Morera-López, Y., Baró-Tomás, T. & Alia-Aponte, C. (2000). In vitro susceptibility of Cryptococcus neoformans isolates to five antifungal drugs using a colorimetric system and the reference microbroth method. J Antimicrob Chemother 45, 645-649.
21. Meyer, W., Aanensen, D. M., Boekhout, T., Cogliati, M., Diaz, M. R., Esposto, M. C., Fisher, M., Gilgado, F., Hagen, F. & other authors (2009). Consensus multi-locus sequence typing scheme for Cryptococcus neoformans and Cryptococcus gattii. Med Mycol 47, 561-570.
22. Park, B. J., Wannemuehler, K. A., Marston, B. J., Govender, N., Pappas, P. G. & Chiller, T. M. (2009). Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/ AIDS. AIDS 23, 525-530.
23. Perfect, J. R., Dismukes, W. E., Dromer, F., Goldman, D. L., Graybill, J. R., Hamill, R. J., Harrison, T. S., Larsen, R. A., Lortholary, O. & other authors (2010). Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis 50, 291-322.
24. Perkins, A., Gomez-Lopez, A., Mellado, E., Rodriguez-Tudela, J. L. & Cuenca-Estrella, M. (2005). Rates of antifungal resistance among Spanish clinical isolates of Cryptococcus neoformans var. neoformans. J Antimicrob Chemother 56, 1144-1147.
25. Pfaller, M. A., Zhang, J., Messer, S., Tumberland, M., Mbidde, E., Jessup, C. & Ghannoum, M. (1998). Molecular epidemiology and antifungal susceptibility of Cryptococcus neoformans isolates from Ugandan AIDS patients. Diagn Microbiol Infect Dis 32, 191-199.
26. Pfaller, M. A., Messer, S. A., Boyken, L., Rice, C., Tendolkar, S., Hollis, R. J., Doern, G. V. & Diekema, D. J. (2005). Global trends in the antifungal susceptibility of Cryptococcus neoformans (1990 to 2004). J Clin Microbiol 43, 2163-2167.
27. Souza, L. K., Fernandes, O. F., Kobayashi, C. C. B. A., Passos, X. S., Costa, C. R., Lemos, J. A., Souza-Júnior, A. H. & Silva, M. R. (2005). Antifungal susceptibilities of clinical and environmental isolates of Cryptococcus neoformans in Goiânia city, Goiás, Brazil. Rev Inst Med Trop Sao Paulo 47, 253-256.
28. Spitzer, E. D., Spitzer, S. G., Freundlich, L. F. & Casadevall, A. (1993). Persistence of initial infection in recurrent Cryptococcus neoformans meningitis. Lancet 341, 595-596.
29. Sullivan, D., Haynes, K., Moran, G., Shanley, D. & Coleman, D. (1996). Persistence, replacement, and microevolution of Cryptococcus neoformans strains in recurrent meningitis in AIDS patients. J Clin Microbiol 34, 1739-1744.
30. Tortorano, A. M., Viviani, M. A., Rigoni, A. L., Cogliati, M., Roverselli, A. & Pagano, A. (1997). Prevalence of serotype D in Cryptococcus neoformans isolates from HIV positive and HIV negative patients in Italy. Mycoses 40, 297-302.
31. van Elden, L. J., Walenkamp, A. M., Lipovsky, M. M., Reiss, P., Meis, J. F., de Marie, S., Dankert, J. & Hoepelman, A. I. (2000). Declining number of patients with cryptococcosis in the Netherlands in the era of highly active antiretroviral therapy. AIDS 14, 2787-2788.
32. Vigouroux, S., Morin, O., Milpied, N., Mahé, B., Rapp, M. J. & Harousseau, J. L. (2000). [Cryptococcus neoformans infection in hematologic malignancies]. Rev Med Interne 21, 955-960 (in French).
33. Viviani, M. A., Cogliati, M., Esposto, M. C., Lemmer, K., Tintelnot, K., Colom Valiente, M. F., Swinne, D., Velegraki, A., Velho, R. & European Confederation of Medical Mycology (ECMM) Cryptococcosis Working Group (2006). Molecular analysis of 311 Cryptococcus neoformans isolates from a 30-month ECMM survey of cryptococcosis in Europe. FEM Yeast Res 6, 614-619.
34. Warkentien, T. & Crum-Cianflone, N. F. (2010). An update on Cryptococcus among HIV-infected patients. Int J STD AIDS 21, 679-684.